HRV Biofeedback for Functional Neurological Disorder
(HRV_BFB_FND Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test how Heart Rate Variability (HRV) biofeedback may assist individuals with Functional Neurological Disorders (FND), which can cause symptoms like unexplained seizures or movement issues. Participants will use a special app and sensor to monitor and potentially improve their heart rate patterns. The trial compares real HRV biofeedback with a placebo version to determine any differences in outcomes. To join, participants need a confirmed FND diagnosis, a smartphone, and the ability to understand French. As an unphased trial, this study offers a unique opportunity to explore innovative treatment options for FND.
Will I have to stop taking my current medications?
If you are taking medications that affect the autonomic nervous system, like certain heart or depression medications, you may need to stop them to join this trial.
What prior data suggests that HRV Biofeedback is safe for patients with Functional Neurological Disorder?
Research shows that HRV (Heart Rate Variability) biofeedback is generally easy to use. In previous studies, patients using HRV biofeedback showed improvements in heart rate patterns and experienced fewer issues related to automatic body functions, such as heart rate and digestion. Another study found that HRV biofeedback helped some patients improve cognitive and motor functions, with no major side effects reported. This suggests that HRV biofeedback is safe for most people. However, as with any treatment, individual reactions may vary. Consulting a healthcare provider is advisable for any concerns.12345
Why are researchers excited about this trial?
Researchers are excited about HRV Biofeedback for Functional Neurological Disorder because it offers a non-invasive and drug-free approach to managing symptoms. Unlike standard treatments, which often involve medications or cognitive behavioral therapy, HRV Biofeedback uses real-time heart rate variability data to help participants regulate their physiological responses. This method harnesses a new mechanism of action by teaching individuals to maximize their heart rate variability, potentially leading to improved emotional and physical well-being. The use of smartphone technology and a Bluetooth ear sensor makes it accessible and user-friendly, providing an innovative way for individuals to engage with their treatment actively.
What evidence suggests that HRV Biofeedback is effective for Functional Neurological Disorder?
Research has shown that Heart Rate Variability (HRV) biofeedback might help improve symptoms in people with Functional Neurological Disorder. In this trial, participants in the experimental group will undergo HRV biofeedback training, which past studies have shown to improve heart function and reduce depression. Other studies have found that HRV biofeedback can lower stress and enhance mental health by helping the body manage stress more effectively. Improved heart rate variability has been linked to better health outcomes, suggesting that HRV biofeedback might help balance automatic body functions like heart rate and stress levels. These findings indicate possible benefits for those with Functional Neurological Disorders.16789
Who Is on the Research Team?
Dang Khoa Nguyen
Principal Investigator
Université de Montréal's affiliated hospital research centre
Are You a Good Fit for This Trial?
This trial is for individuals with Functional Neurological Disorders, which can include symptoms like uncontrolled movements or blackouts without a clear physical cause. Participants should be diagnosed with conditions such as Conversion Disorder or similar nervous system disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Comprehensive clinical evaluation including symptoms, functional capacity, quality of life, and assessment of physical and psychological comorbidities
Treatment
Participants undergo HRV Biofeedback training or placebo training using Inner Balance Coherence Plus® software for 30 days
Crossover Treatment
Participants switch to the alternate intervention (HRV-BFB or placebo) for another 30 days
Follow-up
Participants are monitored for safety and effectiveness after treatment, including repeated measures of symptoms, functional capacity, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- HRV Biofeedback
HRV Biofeedback is already approved in United States, European Union for the following indications:
- Anxiety disorders
- Depression
- Hypertension
- Temporomandibular joint (TMJ) syndrome
- Urinary incontinence
- Fecal incontinence
- Irritable bowel syndrome
- Migraine and tension headaches
- Anxiety disorders
- Depression
- Hypertension
- Temporomandibular joint (TMJ) syndrome
- Urinary incontinence
- Fecal incontinence
- Irritable bowel syndrome
- Migraine and tension headaches
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor
Laboratoire de Psychologie et NeuroCognition
Collaborator